SAN
DIEGO, Nov. 17, 2022 /PRNewswire/ -- NuVasive,
Inc. (NASDAQ: NUVA), the leader in spine technology innovation,
focused on transforming spine surgery with minimally disruptive,
procedurally integrated solutions, held a virtual event yesterday
showcasing the Company's latest innovation across its
market-leading 360 portfolios.
"Changing the lives of patients around the globe is the
foundation of NuVasive—and we fulfill our purpose through a
continued commitment to being the industry's innovation leader,"
said Chris Barry, chief executive
officer at NuVasive. "For more than 20 years, we've
remained focused on transforming the future of spine surgery, and
it's critical that all stakeholders see how our 360 portfolios
integrate with the Pulse platform—and our growing clinical
data—help advance the standard of care."
NuVasive delivered a one-hour, virtual global event sharing
how the Company's portfolios are transforming surgery, advancing
care, and changing patient lives. Attendees heard from members of
the product leadership team and surgeon key opinion leaders across
each spine segment—cervical, anterior, posterior, and complex—and
how the Company's procedural solutions are enabled by the Pulse
platform.
Highlights of the NuVasive Innovation Event by
portfolio:
- C360: Dr. Paul Holman, Houston
Methodist Hospital, and Dr. Michael
Wang, University of Miami Health
System, discussed the future of cervical spine surgery with
enabling technologies. Dr. Holman showcased how he utilizes the MR
imaging1 properties of the Simplify Cervical Disc with
the imaging enhancement application within Pulse to easily confirm
disc placement intraoperatively.
- X360: Dr. Alex Thomas, Atlantic
Brain and Spine, and Dr. Aaron
Buckland, Melbourne Orthopaedic Group, discussed clinical
data around X360 single-position surgery (SPS) and the adoption of
XALIF. Dr. Thomas walked through an X360 case with Pulse,
demonstrating how he's adopted the new technique, approaches
patient selection, builds a surgical plan, and executes to deliver
an optimal patient outcome. He also spoke on the clinical data that
extends over 450 peer-reviewed articles validating XLIF, and
numerous studies in support of X360 SPS.
- P360: Dr. David Yam, Legacy
Health in Portland, Oregon, gave
peers a first look at utilizing the NuVasive Tube System and
Excavation Micro, sharing the benefits of working with a sole
provider for a comprehensive access solution in the prone position.
These new additions to the P360 portfolio provide minimally
invasive surgery options for TLIF and decompression.
- Complex: Dr. Tyler Koski,
Northwestern Medicine, shared a complex posterior cervical fusion
case using the new cervical addition to the Reline system. He
showcased how a fully junctional offering from occiput to sacrum
with Reline Cervical gives him the ability to address the largest
deformity cases within one robust product line.
Surgeons are encouraged to take advantage of the Company's
industry-leading Clinical Professional Development, with
competency-based and cadaveric training programs on NuVasive
procedural solutions. The hands-on experiences can be held at any
of our Experience Centers around the globe—San Diego, New York metropolitan area, or Singapore.
To watch the replay, please visit the NuVasive Innovation Event
microsite here.
1MR Conditional per ASTM F2052, ASTM F2119, ASTM
F2182, ASTM F2213 and ASTM F2503.
Pulse Navigation is not presently indicated for use in cervical
procedures in the EU.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the leader in spine
technology innovation, with a mission to transform surgery, advance
care, and change lives. The Company's less-invasive, procedurally
integrated surgical solutions are designed to deliver reproducible
and clinically proven outcomes. The Company's comprehensive
procedural portfolio includes surgical access instruments, spinal
implants, fixation systems, biologics, software for surgical
planning, navigation and imaging solutions, magnetically adjustable
implant systems for spine and orthopedics, and intraoperative
neuromonitoring technology and service offerings. With more
than $1 billion in net sales, NuVasive operates
in more than 50 countries serving surgeons, hospitals, and
patients. For more information, please
visit www.nuvasive.com.
Forward-Looking
Statements
NuVasive cautions you that statements included in this news
release that are not a description of historical facts are
forward-looking statements that involve risks, uncertainties,
assumptions and other factors which, if they do not materialize or
prove correct, could cause NuVasive's results to differ
materially from historical results or those expressed or implied by
such forward-looking statements. The potential risks and
uncertainties which contribute to the uncertain nature of these
statements include, among others, risks associated with acceptance
of the Company's surgical products and procedures by spine surgeons
and hospitals, development and acceptance of new products or
product enhancements, clinical and statistical verification of the
benefits achieved via the use of NuVasive's products, the
Company's ability to adequately manage inventory as it continues to
release new products, its ability to recruit and retain management
and key personnel, and the other risks and uncertainties described
in NuVasive's news releases and periodic filings with
the Securities and Exchange
Commission. NuVasive's public filings with
the Securities and Exchange Commission are available
at www.sec.gov. NuVasive assumes no obligation to
update any forward-looking statement to reflect events or
circumstances arising after the date on which it was
made.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/nuvasive-showcases-latest-innovation-in-virtual-global-event-301680759.html
SOURCE NuVasive, Inc.